
    
      Type of Study: Translational

      This is a pilot retrospective laboratory-based cohort study.

      Eligible patients will be identified at each one of the participating institutions by a
      systematic cross-matching of the datasets of Medical Oncology, Pathology and Pharmacy
      Departments.

      Patient Population:

      Cohort 1: TNM stage II-IV breast cancer patients with highly trastuzumab-sensitive tumours.

      Cohort 2: (Control group) TNM stage II-IV breast cancer patients with trastuzumab-refractory
      disease.
    
  